The fate of glyoxal and methylglyoxal in peritoneal dialysis.
Lapolla
Annunziata
A
Flamini
Riccardo
R
Aricò
Concetta Nadia
CN
Rugiu
Carlo
C
Reitano
Rachele
R
Ragazzi
Eugenio
E
Seraglia
Roberta
R
Dalla Vedova
Antonio
A
Lupo
Antonio
A
Traldi
Pietro
P
D015314:Dialysis Solutions / Q000009:adverse effects / Q000493:pharmacokinetics*; D005947:Glucose / Q000493:pharmacokinetics; D006037:Glyoxal / Q000009:adverse effects / Q000097:blood / Q000378:metabolism*; D006801:Humans; D010530:Peritoneal Dialysis; D011765:Pyruvaldehyde / Q000009:adverse effects / Q000097:blood / Q000378:metabolism*; D014511:Uremia / Q000378:metabolism / Q000628:therapy*
D015314:Dialysis Solutions; D006037:Glyoxal; D011765:Pyruvaldehyde; D005947:Glucose